252 related articles for article (PubMed ID: 30291567)
1. White matter damage, neuroinflammation, and neuronal integrity in HAND.
Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
[TBL] [Abstract][Full Text] [Related]
2. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
[TBL] [Abstract][Full Text] [Related]
3. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive impairment and gray matter volume reduction in HIV-infected patients.
Kato T; Yoshihara Y; Watanabe D; Fukumoto M; Wada K; Nakakura T; Kuriyama K; Shirasaka T; Murai T
J Neurovirol; 2020 Aug; 26(4):590-601. PubMed ID: 32572834
[TBL] [Abstract][Full Text] [Related]
5. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
[TBL] [Abstract][Full Text] [Related]
6. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
[TBL] [Abstract][Full Text] [Related]
7. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
8. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.
Cooley SA; Paul RH; Fennema-Notestine C; Morgan EE; Vaida F; Deng Q; Chen JA; Letendre S; Ellis R; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Ances BM;
J Neurovirol; 2016 Oct; 22(5):607-614. PubMed ID: 27021072
[TBL] [Abstract][Full Text] [Related]
10. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
12. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.
Paul RH; Yiannoutsos CT; Miller EN; Chang L; Marra CM; Schifitto G; Ernst T; Singer E; Richards T; Jarvik GJ; Price R; Meyerhoff DJ; Kolson D; Ellis RJ; Gonzalez G; Lenkinski RE; Cohen RA; Navia BA
J Neuropsychiatry Clin Neurosci; 2007; 19(3):283-92. PubMed ID: 17827413
[TBL] [Abstract][Full Text] [Related]
13. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
16. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
Taylor MJ; Schweinsburg BC; Alhassoon OM; Gongvatana A; Brown GG; Young-Casey C; Letendre SL; Grant I;
J Neurovirol; 2007 Apr; 13(2):150-9. PubMed ID: 17505983
[TBL] [Abstract][Full Text] [Related]
17. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
18. Increased glial metabolites predict increased working memory network activation in HIV brain injury.
Ernst T; Chang L; Arnold S
Neuroimage; 2003 Aug; 19(4):1686-93. PubMed ID: 12948723
[TBL] [Abstract][Full Text] [Related]
19. Effects of comorbidity burden and age on brain integrity in HIV.
Saloner R; Heaton RK; Campbell LM; Chen A; Franklin D; Ellis RJ; Collier AC; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Fennema-Notestine C;
AIDS; 2019 Jun; 33(7):1175-1185. PubMed ID: 30870195
[TBL] [Abstract][Full Text] [Related]
20. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
